Cabozantinib,Nivolumab,Ipilimumab
Exelixis,bms
['cabozantinib', 'rcc,(-irccs),(-srcc),(-urcc)']
addition of cabozantinib to frontline soc improves pfs in advanced rcc #esmo22 #urology #urologist #kidneycancer
Expert clinical analysis. Practice advice. Policy perspectives.